Patents by Inventor Weiying Yang

Weiying Yang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AUGMENTED COOLING SYSTEM FOR VEHICLES POWERED BY FUEL CELLS
    Publication number: 20230294559
    Abstract: A cooling system comprises a liquid storage tank and liquid disposed within the liquid storage tank. A first heat exchanger is immersed within the liquid, wherein refrigerant from an air conditioning system flows through the first heat exchanger. A second heat exchanger is also immersed within the liquid, wherein coolant from a load cooling system flows through the second heat exchanger.
    Type: Application
    Filed: March 17, 2022
    Publication date: September 21, 2023
    Applicant: International Engine Intellectual Property Company, LLC
    Inventors: Shouhao Wu, Weiying Yang
  • ENERGY RECOVERY USING SUPERCAPACITORS
    Publication number: 20230299609
    Abstract: An electrical energy recovery, storage, and distribution system that may be used in a vehicle. The system may include a supercapacitor configured to quickly store large amounts of energy. The system may also include multiple circuits operating at different voltage levels, such that an output voltage from the supercapacitor is useful over a larger voltage range and the system is more energy efficient.
    Type: Application
    Filed: March 18, 2022
    Publication date: September 21, 2023
    Applicant: International Engine Intellectual Property Company, LLC
    Inventors: Shouhao Wu, Weiying Yang
  • 2,3-substituted indole derivatives for treating viral infections
    Patent number: 8143305
    Abstract: The present invention relates to 2,3-Substituted Indole Derivatives, compositions comprising at least one 2,3-Substituted Indole Derivative, and methods of using the 2,3-Substituted Indole Derivatives for treating or preventing a viral infection or a virus-related disorder in a patient.
    Type: Grant
    Filed: August 27, 2008
    Date of Patent: March 27, 2012
    Assignee: Schering Corporation
    Inventors: Gopinadhan N. Anilkumar, Frank Bennett, Tin-Yau Chan, Kevin X. Chen, Mousumi Sannigrahi, Francisco Velazquez, Srikanth Venkatraman, Qingbei Zeng, Jose S. Duca, Charles A. Lesburg, Joseph A. Kozlowski, F. George Njoroge, Stuart B. Rosenblum, Neng-Yang Shih, Stephen J. Gavalas, Yueheng Jiang, Patrick A. Pinto, Haiyan Pu, Oleg B. Selyutin, Bancha Vibulbhan, Li Wang, Wanli Wu, Weiying Yang, Yuhua Huang, Hsueh-Cheng Huang, Robert Palermo, Boris Feld
  • 2,3-SUBSTITUTED INDOLE DERIVATIVES FOR TREATING VIRAL INFECTIONS
    Publication number: 20110033417
    Abstract: The present invention relates to 2,3-Substituted Indole Derivatives, compositions comprising at least one 2,3-Substituted Indole Derivative, and methods of using the 2,3-Substituted Indole Derivatives for treating or preventing a viral infection or a virus-related disorder in a patient.
    Type: Application
    Filed: August 27, 2008
    Publication date: February 10, 2011
    Inventors: Gopinadhan N. Anilkumar, Frank Bennett, Tin-Yau Chan, Kevin X. Chen, Mousumi Sannigrahi, Francisco Velazquez, Srikanth Venkatraman, Qingbei Zeng, Jose S. Duca, Charles A. Lesburg, Joseph A. Kozlowski, F. George Njoroge, Stuart B. Rosenblum, Neng-Yang Shih, Stephen J. Gavalas, Yueheng Jiang, Patrick A. Pinto, Haiyan Pu, Oleg B. Selyutin, Bancha Vibulbhan, Li Wang, Wanli Wu, Weiying Yang, Yuhua Huang, Hsueh-Cheng Huang, Robert Palermo, Boris Feld
  • Ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus
    Patent number: 7619094
    Abstract: The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
    Type: Grant
    Filed: November 20, 2006
    Date of Patent: November 17, 2009
    Assignee: Schering Corporation
    Inventors: Kevin X Chen, F George Njoroge, Mousumi Sannigrahi, Latha G Nair, Weiying Yang, Bancha Vibulbhan, Srikanth Venkatraman, Ashok Arasappan, Stephane L. Bogen, Frank Bennett, Viyyoor M. Girijavallabhan
  • Peptidomimetic NS3-serine protease inhibitors of hepatitis C virus
    Patent number: 7449447
    Abstract: The present application discloses a compound, or enantiomers, stereoisomers, rotamers, tautomers, racemates or prodrug of said compound, or pharmaceutically acceptable salts or solvates of said compound, or of said prodrug, said compound having the general structure shown in Formula 1: useful in the treatment or prevention or amelioration of one or more symptoms of hepatitis C.
    Type: Grant
    Filed: August 24, 2004
    Date of Patent: November 11, 2008
    Assignee: Schering Corporation
    Inventors: Kevin X. Chen, F. George Njoroge, Weiying Yang, Bancha Vibulbhan, Viyyoor M. Girijavallabhan, Srikanth Venkatraman, Francisco Velazquez
  • Novel ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus
    Publication number: 20070093430
    Abstract: The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
    Type: Application
    Filed: November 20, 2006
    Publication date: April 26, 2007
    Inventors: Kevin Chen, F. Njoroge, Mousumi Sannigrahi, Latha Nair, Weiying Yang, Bancha Vibulbhan, Srikanth Venkatraman, Ashok Arasappan, Stephane Bogen, Frank Bennett, Viyyoor Girijavallabhan
  • Ketoamides with cyclic P4'S as inhibitors of NS3 protease of hepatitis C virus
    Patent number: 7173057
    Abstract: The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
    Type: Grant
    Filed: February 24, 2005
    Date of Patent: February 6, 2007
    Assignee: Schering Corporation
    Inventors: Kevin X. Chen, F. George Njoroge, Mousumi Sannigrahi, Latha G. Nair, Weiying Yang, Bancha Vibulbhan, Srikanth Venkatraman, Ashok Arasappan, Stephane L. Bogen, Frank Bennett, Viyyoor M. Girijavallabhan
  • Novel ketoamides with cyclic P4'S as inhibitors of NS3 protease of hepatitis C virus
    Publication number: 20050222047
    Abstract: The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
    Type: Application
    Filed: February 24, 2005
    Publication date: October 6, 2005
    Inventors: Kevin Chen, F. Njoroge, Mousumi Sannigrahi, Latha Nair, Weiying Yang, Bancha Vibulbhan, Srikanth Venkatraman, Ashok Arasappan, Stephane Bogen, Frank Bennett, Viyyoor Girijavallabhan
  • Novel peptidomimetic NS3-serine protease inhibitors of hepatitis C virus
    Publication number: 20050085425
    Abstract: The present application discloses a compound, or enantiomers, stereoisomers, rotamers, tautomers, racemates or prodrug of said compound, or pharmaceutically acceptable salts or solvates of said compound, or of said prodrug, said compound having the general structure shown in Formula 1: useful in the treatment or prevention or amelioration of one or more symptoms of hepatitis C.
    Type: Application
    Filed: August 24, 2004
    Publication date: April 21, 2005
    Inventors: Kevin Chen, F. Njoroge, Weiying Yang, Bancha Vibulbhan, Viyyoor Girijavallabhan, Srikanth Venkatraman, Francisco Velazquez
  • Dehydrogenating catalyst for saturate hydrocarbons
    Patent number: 5358920
    Abstract: A dehydrogenating catalyst for saturated hydrocarbons comprising platinum, tin, sodium and .tau.-alumina. The support of the catalyst is a large pore diameter .tau.-Al.sub.2 O.sub.3 with dual pore diameter distribution. At least 40% of the total pore volume is contributed by pores with pore diameter in the range of 1000-10000 .ANG.. Platinum, tin, and sodium are impregnated onto support by co-impregnation method, followed by drying, calcinating, and steam-treating, as well as reducing by hydrogen, to prepare a long life dehydrogenating catalyst.
    Type: Grant
    Filed: November 19, 1993
    Date of Patent: October 25, 1994
    Assignees: China Petro-Chemical Corporation, Jing Ling Petrochemical Company, Sinopec
    Inventors: Yongfu Ma, Peicheng Wu, Yong Sun, Sangjian Zhu, Yuexin Huang, Weiying Yang, Kaiwen Yao, Youreng Zou